Pure red cell aplasia associated with myelodysplastic syndromes
- 31 August 2000
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 14 (9) , 1709-1710
- https://doi.org/10.1038/sj.leu.2401833
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Poor response rate to a continuous schedule of Amifostine therapy for ‘low/intermediate risk’ myelodysplastic patientsBritish Journal of Haematology, 1998
- Myelodysplastic syndrome with erythroid hypoplasia/aplasia: A case report and review of the literatureAmerican Journal of Hematology, 1998
- Stimulation of Hematopoiesis by Amifostine in Patients With Myelodysplastic SyndromeBlood, 1997
- Immunosuppressive therapy for hypoplastic myelodysplastic syndromeCancer, 1997
- Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities [see comments]Blood, 1996
- Red cell aplasia in myelodysplastic syndrome.Journal of Clinical Pathology, 1991
- Pure red cell aplasia: lymphocyte inhibition of erythropoiesisBritish Journal of Haematology, 1986
- The 5q – syndrome: an underdiagnosed form of macrocytic anaemiaBritish Journal of Haematology, 1983